Remove 2008 Remove Communication Remove Documentation Remove Pharmaceutical Companies
article thumbnail

CMC Requirements for New Drug Registration in Latin America

ISPE

In an era when the world is accelerating the development of drugs and targeted medicines using innovative technologies, pharmaceutical companies still face registration hurdles for well-characterized molecules because of redundant or additional local regulatory requirements.

article thumbnail

A New Regulatory Approach to Drive Sustainable Medicines

ISPE

A pharmaceutical quality system (PQS) is a management system used to direct and control a pharmaceutical company with regard to quality. Guideline on the Requirements to the Chemical and Pharmaceutical Quality Documentation Concerning Investigational Medicinal Products in Clinical Trials.” Published June 2008.

article thumbnail

An Evaluation of Postapproval CMC Change Timelines

ISPE

In the dynamic global environment, the approval times for postapproval changes can be expected to change over time and may well differ between pharmaceutical companies based on different practices and approaches. You may unsubscribe from these ISPE communications at any time. The proposals are consistent with WHO GRP.